enteroviru
infect
among
common
type
viru
infect
human
major
infect
subclin
occasion
caus
diseas
common
cold
diseas
hfmd
myocard
mening
otiti
media
neonat
sepsi
pancreat
poliomyel
sinus
addit
enteroviru
infect
associ
inflammatori
diseas
type
diabet
asthma
allergi
understand
complex
process
lead
differ
disord
limit
better
knowledg
virus
interact
host
essenti
discoveri
mechan
identif
target
develop
therapeut
measur
enterovirus
encod
two
proteas
essenti
cleavag
viral
polyprotein
protein
proteas
also
cleav
protein
cellular
target
alreadi
identifi
includ
transcript
factor
protein
control
nuclear
importexport
protein
pattern
recognit
receptor
prr
protein
mani
involv
activ
host
immun
respons
cleavag
protein
may
contribut
patholog
better
insight
target
specif
enterovir
proteas
coupl
inform
protein
cleavag
affect
biolog
function
cell
like
reveal
novel
diseas
mechan
well
identifi
way
treat
prevent
diseas
molecular
characterist
natur
replic
morpholog
physiochem
properti
virion
defin
genu
enteroviru
genu
belong
famili
picornavirida
order
picornaviral
genu
divid
twelv
speci
enteroviru
j
rhinoviru
enteroviru
virion
contain
singl
posit
strand
rna
genom
length
around
kb
genom
dens
pack
icosahedr
capsid
compos
copi
four
separ
viral
capsid
protein
upon
infect
capsid
undergo
structur
chang
caus
releas
viral
genom
cytoplasm
undergo
translat
translat
machineri
host
enteroviru
genom
encod
singl
open
read
frame
result
translat
viral
protein
singl
polyprotein
enterovirus
use
sever
type
molecul
bind
initi
entri
cell
figur
major
known
enteroviru
receptor
belong
immunoglobulin
superfamili
igsf
specif
type
transmembran
glycoprotein
includ
intracellular
adhes
molecul
receptor
car
polioviru
receptor
pvr
type
receptor
includ
decay
acceler
factor
daf
lipoprotein
receptor
scaveng
receptor
integrin
tissu
cell
distribut
viru
receptor
import
determin
viru
tropism
poliovirus
primarili
infect
human
gastrointestin
lymphoid
tissu
tonsil
peyer
patch
express
pvr
viru
spread
circul
thereaft
central
nervou
system
neuron
cell
express
pvr
becom
infect
result
muscl
weak
paralysi
attach
receptor
enterovirus
gain
access
cell
via
endocytot
pathway
rout
entri
depend
speci
viru
cell
type
pathway
well
intern
rout
describ
possibl
entri
mechan
presenc
receptor
cell
surfac
howev
determin
cellular
permiss
viru
may
enter
cell
fail
replic
exampl
lack
endogen
cellular
protein
requir
viral
propag
exampl
endogen
protein
polypyrimidin
protein
ptb
altern
cell
enter
antivir
state
therebi
may
permiss
infect
review
therefor
depend
variou
cellular
factor
make
host
suscept
permiss
infect
multifacet
complex
phenomenon
endocytosi
viru
particl
undergo
structur
chang
result
uncoat
viral
genom
engag
capsid
protein
endosom
membran
presum
via
allow
deliveri
viral
rna
vpg
protein
tract
cytosol
translat
host
ribosom
viral
polyprotein
polyprotein
encod
singl
open
read
frame
divid
three
region
figur
region
contain
four
structur
protein
wherea
region
togeth
contain
seven
protein
requir
differ
stage
virus
replic
cycl
proteolyt
process
polyprotein
separ
protein
alreadi
initi
translat
viral
proteas
region
encod
structur
protein
capsid
first
one
translat
follow
region
contain
three
protein
translat
region
translat
first
make
ci
cleavag
separ
region
region
full
polyprotein
translat
translat
continu
region
region
includ
second
proteas
respons
eight
cleavag
viral
polyprotein
cleavag
carri
two
proteas
give
rise
protein
sever
precursor
protein
three
structur
protein
cleav
unknown
mechan
may
entail
autocatalyt
reaction
encapsid
process
viral
replic
take
place
proxim
membran
vesicl
deriv
partli
endoplasm
reticulum
posit
strand
rna
transcrib
viral
encod
polymeras
complementari
neg
strand
rna
rna
synthesi
prime
associ
replic
complex
recruit
end
neg
strand
viral
genom
initi
rna
synthesi
neg
strand
rna
serv
templat
transcript
posit
strand
rna
genom
multipl
rna
synthes
singl
templat
make
rna
abund
directli
avail
translat
synthesi
addit
rna
encapsid
figur
accumul
newli
synthes
viral
rna
structur
protein
lead
packag
viral
genom
capsid
thu
form
new
viral
progeni
surprisingli
littl
known
encapsid
process
studi
indic
process
viru
assembl
coupl
rna
synthesi
surfac
cytoplasm
membran
classic
view
enteroviru
releas
occur
cell
lysi
intriguingli
new
observ
challeng
model
extracellular
vesicl
shed
host
cell
could
potenti
dissemin
infect
persist
enteroviru
infect
without
evid
cytopath
effect
tissu
cell
model
also
report
support
recent
describ
nonlyt
model
viru
releas
enterovir
diseas
poliomyel
caus
three
differ
polioviru
serotyp
poliomyel
virtual
erad
develop
countri
recent
two
enterovirus
enteroviru
enteroviru
demonstr
caus
acut
flaccid
paralysi
resembl
poliomyel
moreov
coxsackieviru
caus
hfmd
enterovirus
coxsackievirus
cvb
particular
associ
acut
myocard
later
develop
dilat
cardiomyopathi
diseas
relat
enteroviru
infect
may
result
either
acut
infect
appear
acut
phase
indic
may
differ
mechan
contribut
tissu
patholog
acut
infect
typic
associ
local
inflamm
eg
common
cold
otiti
pancreat
hepat
clear
rel
rapidli
immun
system
contrast
condit
like
dilat
cardiomyopathi
syndrom
like
result
infect
complet
clear
enter
persist
infect
phase
although
poliomyel
caus
polioviru
studi
diseas
surprisingli
littl
known
diseas
mechan
even
less
known
enterovirus
caus
diseas
eg
except
howev
myocard
subsequ
develop
chronic
dilat
myopathi
latter
sever
condit
usual
lead
heart
failur
acut
phase
infect
proteas
cleav
cellular
protein
dystrophin
lead
sarcolemm
disrupt
reduct
myocyt
contractil
recent
public
matthew
et
al
postul
detail
molecular
mechan
damag
caus
infect
name
cleavag
product
retain
sarcoglycan
complex
turn
decoupl
actin
sarcolemma
subsequ
prevent
recoveri
dystrophin
sarcolemm
membran
contribut
impair
cardiac
function
cleavag
transcript
factor
serum
respons
factor
srf
srf
normal
highli
express
heart
muscl
cell
contribut
regul
express
heart
gene
includ
contractil
regulatori
protein
well
mirna
control
specif
heart
cell
function
break
transactiv
domain
srf
therebi
diminish
express
gene
regul
transcript
factor
coxsackievirus
shown
caus
persist
infect
heart
anim
model
human
characterist
persist
cvb
infect
also
contain
delet
vari
size
end
persist
infect
may
lead
chronic
immun
respons
also
possibl
autoimmun
respons
exemplifi
antibodi
respons
cardiac
antigen
cardiac
myosin
troponin
chronic
inflamm
like
contribut
cardiac
dysfunct
enteroviru
proteas
multifunct
cystein
proteas
belong
endopeptidas
proteas
famili
merop
compar
primari
sequenc
align
consensu
sequenc
show
ident
even
though
two
proteas
strikingli
similar
tertiari
structur
figur
among
differ
speci
enterovirus
proteas
share
approxim
sequenc
ident
rhinovirus
diverg
group
around
ident
speci
figur
amino
acid
residu
catalyt
triad
fulli
conserv
throughout
enteroviru
genu
addit
amino
acid
residu
surround
catalyt
residu
conserv
compar
rest
protein
indic
similar
mechan
involv
sequenc
specif
cleavag
among
enterovir
proteas
tertiari
structur
proteas
compos
two
separ
domain
case
two
domain
includ
antiparallel
barrel
pile
pack
side
figur
tertiari
structur
combin
two
twist
pack
perpendicular
proteas
two
domain
particip
format
posit
catalyt
triad
catalyt
triad
compos
histidin
aspart
acid
cystein
case
histidin
glutam
acid
cystein
case
cystein
catalyt
triad
act
nucleophil
proteolyt
reaction
proteas
characterist
proteas
also
conserv
motif
locat
opposit
side
catalyt
activ
site
zinc
ion
locat
one
end
barrel
bound
three
cystein
one
histidin
residu
chlorin
ion
bound
stretch
resid
loop
connect
two
barrel
monomer
dimer
quaternari
structur
form
report
liebig
et
al
found
show
dimer
state
gel
filtrat
analysi
found
monomer
anoth
studi
found
monomer
gel
filtrat
analysi
studi
cai
et
al
found
form
dimer
neglig
interfac
crystal
structur
oligomer
state
solut
could
shown
mu
et
al
crystal
found
monom
asymmetr
unit
anoth
recent
studi
dimer
hexamer
quaternari
assembl
solut
crystal
report
hexamer
form
found
dissoci
dimer
addit
dtt
could
indic
hexam
present
reduc
intracellular
environ
dimer
hexam
separ
size
exclus
chromatographi
exhibit
equal
effici
proteolyt
activ
like
quaternari
structur
monomer
lack
third
domain
whose
import
shown
dimer
relat
coronaviru
proteas
contrast
observ
solv
crystal
structur
proteas
assembl
dimer
exampl
show
dimer
assembl
crystal
structur
contrari
found
monomer
gel
filtrat
dl
experi
therefor
dimer
observ
crystal
like
repres
biolog
relev
form
sequenc
specif
specif
sequenc
proteas
abl
cleav
establish
studi
comprehens
date
amino
acid
residu
recogn
import
determin
sequenc
specif
enterovir
proteas
figur
substrat
recognit
import
residu
exclus
glycin
follow
order
import
occupi
mainli
threonin
asparagin
occupi
prolin
alanin
phenylalanin
occupi
frequent
leucin
threonin
residu
show
least
amount
varianc
substrat
sequenc
prefer
residu
posit
glutamin
glutam
glycin
asparagin
serin
addit
common
residu
alanin
posit
prolin
posit
obviou
featur
determin
substrat
specif
strong
conserv
glycin
residu
posit
present
understand
residu
import
posit
may
revis
new
inform
becom
avail
refer
method
identifi
new
cellular
substrat
enterovir
proteas
cleavag
predict
use
silico
analysi
techniqu
bioinformat
section
succeed
text
process
enterovir
polyprotein
indispens
viru
replic
viral
proteas
recogn
potenti
target
antivir
intervent
two
proteas
particular
consid
compel
target
polyprotein
sever
cleavag
site
specif
proteas
mani
inhibitor
develop
studi
small
molecul
peptid
mimet
target
activ
site
proteas
small
molecular
compound
also
describ
structur
conserv
commonli
share
proteolyt
mechan
seen
differ
viral
proteas
make
possibl
develop
inhibitor
antivir
activ
toward
mani
speci
enteroviru
genu
furthermor
occasion
activ
toward
distantli
relat
virus
inhibitor
candid
includ
pyrazol
compound
target
differ
enterovirus
well
coronaviru
proteas
homologu
microcycl
inhibitor
enteroviru
homologu
addit
lycorin
deriv
shown
inhibit
stabil
special
conform
zinc
finger
motiv
similarli
furthermor
act
homolog
zinc
finger
hepat
c
viru
proteas
rhinoviru
inhibitor
rupintrivir
also
activ
norovirus
date
compound
studi
rupintrivir
analogu
compound
progress
clinic
trial
develop
therapeut
rhinoviru
infect
sinc
stall
possibl
result
limit
activ
clinic
trial
recent
rupintrivir
howev
gain
renew
attent
prove
effect
interest
optimist
result
put
renew
focu
develop
antivir
target
viral
proteas
possibl
one
sever
novel
drug
candid
may
show
efficaci
clinic
trial
reach
market
come
year
mention
preced
text
enteroviru
proteas
fulfil
sever
function
addit
cleav
viral
polyprotein
matur
viral
protein
exampl
cleav
cellular
protein
order
favour
viral
propag
cellular
protein
product
proteas
interfer
shut
protein
synthesi
cleavag
eukaryot
translat
initi
factor
gamma
essenti
compon
rna
translat
machineri
enterovirus
lack
cap
cleavag
affect
viral
protein
synthesi
instead
enterovirus
use
highli
order
secondari
structur
end
viral
rna
call
intern
ribosom
entri
site
ire
achiev
initi
translat
gene
transcript
also
affect
enteroviru
infect
infect
precursor
protein
enter
nucleu
inhibit
transcript
cellular
protein
cleavag
tata
box
camp
respons
protein
octam
bind
transcript
factor
transcript
activ
factor
although
polymeras
contain
nuclear
local
signal
nl
recent
studi
show
proteolysi
requir
nuclear
transloc
addit
direct
cleavag
cellular
protein
tabl
complet
list
publish
substrat
refer
tabl
proteas
also
indirectli
affect
cellular
protein
promot
viral
replic
exampl
target
sever
nuclear
pore
complex
npc
protein
like
disrupt
npc
result
rearrang
nuclear
protein
cytoplasm
viral
replic
occur
exampl
protein
redistribut
process
cellular
splice
factor
bind
cellular
protein
poli
rc
protein
pcbp
recruit
ribosom
replic
viral
rna
promot
initi
translat
thu
reloc
cellular
transcript
factor
util
modul
viral
translat
later
stage
gener
new
viral
rna
genom
infect
cell
sever
intracellular
receptor
recogn
differ
type
virus
enterovirus
form
dsrna
structur
replic
main
known
receptor
respons
sens
enterovirus
interferon
induc
helicas
c
domain
locat
cytoplasm
receptor
endosom
close
relat
prr
retino
gene
signal
via
common
adaptor
protein
call
mitochondri
protein
mav
signal
via
trif
signal
via
mav
trif
result
phosphoryl
sever
transcript
factor
nfkb
migrat
nucleu
induc
express
type
iii
interferon
ifn
well
inflammatori
cytokin
figur
secret
ifn
act
autocrin
paracrin
manner
trigger
cell
enter
antivir
state
induc
express
gene
isg
addit
manipul
cellular
protein
favour
viral
replic
enterovirus
also
util
proteas
escap
recognit
immun
system
shown
cleav
sever
protein
within
viral
recognit
pathway
thu
inhibit
induct
ifn
exampl
viral
sensor
like
target
proteas
addit
trif
mav
adaptor
protein
two
major
rna
sens
pathway
cleav
downstream
protein
like
transcript
factor
target
well
also
shown
act
directli
interferon
receptor
reduc
express
therebi
impair
efficaci
ifn
treatment
infect
given
note
enterovir
proteas
contribut
diseas
patholog
eg
cleavag
dystrophin
heart
muscl
possibl
enterovir
diseas
also
associ
proteolyt
activ
andor
identif
addit
protein
target
proteas
may
thu
lead
identif
novel
diseas
mechan
enterovirus
abl
caus
divers
diseas
affect
differ
tissu
organ
may
also
relev
understand
proteas
act
specif
tissu
cell
number
approach
use
studi
cellular
target
includ
infect
cell
tissu
exampl
select
overexpress
viral
proteas
transfect
exampl
transgen
techniqu
varieti
vitro
assay
proteas
incub
cell
lysat
exampl
silico
predict
cleavag
site
base
amino
acid
sequenc
composit
potenti
target
protein
analys
whether
experiment
approach
result
cleavag
enterovir
enzym
western
blot
frequent
use
method
western
blot
possibl
observ
appear
cleavag
product
andor
decreas
concentr
potenti
target
protein
eg
figur
howev
antibodi
may
recogn
produc
fragment
analysi
cumbersom
transfect
studi
use
reveal
protein
respons
effect
observ
infect
cell
nevertheless
conduct
transfect
studi
overexpress
select
viral
protein
caveat
may
function
viral
protein
might
depend
viral
protein
exampl
also
must
taken
account
proteas
precursor
could
differ
protein
target
compar
matur
proteas
technic
limit
mention
preced
text
may
provid
explan
contradictori
report
literatur
one
studi
indic
coxsackieviru
cleav
mav
studi
suggest
cleavag
mediat
enteroviru
infect
also
activ
endogen
proteas
includ
caspas
also
cleav
cellular
protein
barral
et
al
show
apoptosi
cours
infect
correl
cleavag
cleavag
also
appear
cell
treat
puromycin
induc
apoptosi
thu
activ
endogen
proteas
may
result
erron
identif
protein
target
anoth
drawback
analys
describ
preced
text
research
identifi
protein
interest
address
whether
affect
proteas
outcom
one
cellular
protein
studi
time
order
overcom
shortag
approach
present
weng
et
al
identifi
new
substrat
use
nuclear
extract
treat
vitro
treat
lysat
analys
combin
electrophoresi
mass
spectrometri
identifi
eight
novel
substrat
analys
cleavag
stimul
factor
detail
newer
methodolog
quantit
proteom
recent
use
studi
enterovirus
affect
proteom
method
may
also
appli
identifi
new
proteas
target
potenti
disadvantag
type
analys
restrict
protein
express
infect
cell
provid
simultan
analysi
whole
human
proteom
sequenc
structur
viral
polyprotein
well
identifi
cellular
target
may
form
basi
predict
novel
cellular
protein
substrat
comprehens
work
complet
predict
new
cleavag
site
enterovir
proteas
perform
blom
et
al
use
neural
network
algorithm
predict
studi
use
collect
known
cleavag
site
teach
algorithm
predict
potenti
cleavag
site
algorithm
score
amino
acid
sequenc
potenti
cleavag
site
base
two
calcul
paramet
first
sequenc
specif
second
surfac
access
algorithm
publish
avail
free
tool
internet
netpicorna
server
http
wwwcbsdtudkservicesnetpicorna
netpicorna
server
seem
howev
underestim
number
cleavag
target
exampl
recogn
potenti
candid
number
cleavag
target
may
overestim
time
public
server
limit
number
cellular
substrat
known
may
caus
bia
certain
kind
cleavag
site
addit
surfac
access
predict
base
resolv
structur
ab
initio
primari
sequenc
analysi
amino
acid
composit
protein
mani
new
substrat
identifi
sinc
tabl
tabl
refer
therein
larg
amount
human
proteom
structur
data
avail
inde
end
year
number
structur
report
pdb
number
increas
therefor
may
worth
revis
sequenc
specif
well
surfac
access
predict
aim
develop
improv
algorithm
use
identifi
novel
substrat
work
ongo
laboratori
enterovirus
import
human
pathogen
whose
manifest
rang
subclin
infect
sever
diseas
hospit
visit
symptomat
treatment
sever
infect
costli
clear
better
understand
complex
diseas
mechan
underli
diseas
would
lead
efficaci
treatment
diseas
mechan
identifi
near
futur
addit
one
like
discov
research
team
integr
mani
scientif
disciplin
bioinformat
molecular
biolog
proteom
use
patient
materi
sever
patholog
mechan
may
explain
activ
viral
proteas
effect
shut
protein
synthesi
immun
evas
well
hijack
cellular
machineri
favour
viru
propag
may
common
enterovirus
howev
especi
persist
type
infect
product
viral
protein
includ
proteas
continu
month
year
degrad
host
protein
may
may
lead
select
patholog
process
eg
myocard
develop
dilat
cardiomyopathi
current
limit
number
studi
address
role
proteas
manner
better
tool
global
identifi
verifi
proteas
target
assist
identif
novel
cellular
protein
substrat
without
limit
particular
cell
type
overal
provid
better
understand
proteas
concert
viral
protein
contribut
induct
differ
diseas
inform
also
immedi
import
develop
novel
drug
includ
proteas
inhibitor
prevent
treat
diseas
caus
enterovirus
new
predict
method
approach
critic
success
complet
goal
author
compet
interest
